Naviscan PET Systems a privately held company that manufactures and develops high-resolution PET scanners launched its second generation of PEM devices, the PEM Flex Solo II.

PEM Flex Solo II an organ-specific, high-resolution PET scanner. Solo II is intended for use as an adjunct imaging modality and utilizes Positron Emission Mammography (PEM). PEM is a specialized form of PET technology that provides radiologists, breast surgeons, oncologists and nuclear medicine a new tool to image and characterize the scope of the disease at a metabolic rate.

Photonics improvements in the new Solo II yields higher count rate sensitivity while maintaining resolution capabilities that image cancers as small as 1.5 - 2.0mm, unprecedented in any other modality. The Solo II has also added an articulating arm, a motorized C-arm, and compression capability, enabling technologists to more easily position patients for optimal views and improved chest wall access.

In addition to its superior resolution capabilities, studies have shown the PEM Flex system has demonstrated sensitivity and specificity greater than 90 percent for characterizing suspicious lesions. The system has a positive predictive value of 92 percent.


Related Content

News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Molecular Imaging

Editor's Note: This article has been updated to correct an earlier version. Oct. 15, 2026 — GE HealthCare has announced ...

Time October 16, 2026
arrow
News | Information Technology

October 6, 2026 – Clearsense has introduced a cloud-based medical image archive designed to reduce the cost of ...

Time October 07, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 5, 2026 — GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based CMO for PET ...

Time October 06, 2026
arrow
News | PET-MRI

Sept. 29, 2026 —Yale New Haven Hospital has installed a state-of-the-art positron emission tomography/magnetic resonance ...

Time October 05, 2026
arrow
News | Radiopharmaceuticals and Tracers

Aug. 30, 2026 — Bayer has announced the presentation of first detailed results from the Phase III REVEAL study, an ...

Time September 02, 2026
arrow
News | PET-MRI

June 10, 2026 — UTHealth Houston has launched a state-of-the-art PET/MRI imaging service, bringing together two advanced ...

Time June 12, 2026
arrow
News | Nuclear Imaging

June 1, 2026 — At the 2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, GE HealthCare will ...

Time June 02, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...

Time May 08, 2026
arrow
Subscribe Now